Reveal® Q+ for d9-THC in Hemp

Item No.  8024

  • Rapid test which can be performed on-site during the growing season
  • Get more data points per dollar and take control of Δ9-THC monitoring
  • Protect your crop by ensuring it stays under the legal limit
This item has shipping restrictions.
$400.00 each
In stock
Out of stock
Expect availability in 2-4 weeks
Minimum quantity required: 1
This item must be ordered in multiples of one case. Quantity per case: 1
The Reveal® Q+ for d9-THC in Hemp rapid endpoint test was designed to quantify and monitor Δ9-THC concentrations in hemp throughout the growing season. The test was developed for use on the farm. It removes the need to send samples to an analytical lab, reducing expenses and time to result. However, this test does not replace the final Δ9-THC quantification by a certified analytical lab before harvest.
Brand Reveal®
Analyte Δ9-THC
Platform Lateral Flow
Result Type Quantitative
Testing Time 2.00 4.00
Time to Result 5
Storage Conditions 18–30°C (64–86°F)
Quantity per Package 25 tests
  • 25 Reveal Q+ test strips
  • 25 prefilled sample dilution bottles
  • 25 clear sample cups
  1. Raptor Solo Integrated Analysis Platform reader (Neogen item 9696)
  2. Decarboxylator (Neogen item 8026)
  3. THC extraction materials
    1. Cups with lids for sample collection (125 mL; Neogen item 9428)
    2. 70% isopropyl rubbing alcohol
  4. Agri-grind grinder or equivalent (Neogen item 9401, 9453)
  5. Scale capable of weighing 1 g ± 0.1 g (Neogen item 9427)
  6. Fixed volume 100 μL pipet (Neogen item 9860)
  7. 200 μL pipet tips (Neogen item 9407, 9410, 9417)
  8. 25 mL graduated cylinder (Neogen item 90447)
  9. Food dehydrator for drying down the sample before decarboxylation


Reveal Q+ for d9-THC in Hemp is a single-step lateral flow immunoassay. It is used to test dried hemp flower samples that are decarboxylated to convert the THCA to total Δ9-THC. The decarboxylated hemp samples are ground and extracted with isopropanol to solubilize the Δ9-THC. The test strip is added to a small sample cup containing the diluted hemp extract. The extract is wicked through the reagent zone, which contains antibodies specific for Δ9-THC bound to a gold nanoparticle. If Δ9-THC is present, it will be captured by the antibody. The extract is then wicked onto a membrane containing a zone of Δ9-THC conjugated to a protein carrier. This zone captures any unbound gold nanoparticles, allowing the particles to concentrate and form a visible line.

As the level of Δ9-THC in a sample increases, free Δ9-THC will bind with the gold nanoparticle allowing the less gold complex to be captured in the test zones. Therefore, as the concentration of Δ9-THC in the sample increases, the test line density decreases. The membrane also contains a control zone where an immune complex present in the reagent zone is captured by an antibody, forming a visible line. The control line will always form regardless of the presence of Δ9-THC, ensuring the strip is functioning properly. This assay is analyzed exclusively with the Raptor® Solo Integrated Analysis Platform. The reader quantifies the amount of total Δ9-THC in a sample based on the ratio of the test line intensity and the control line intensity. Algorithms programmed into the Raptor Solo reader convert the line intensities into a quantitative result displayed in percent (%) THC on the reader’s screen.



Our customers’ success is our shared success. Our experts are ready to train you and your team on our solutions, so you can rest easy knowing procedures are performed properly and yield accurate results. In addition, we provide certificates upon completion of training to provide you with the documentation needed for audit traceability.



Our experts are here to help. If you need information beyond what is provided in Validation Reports under the Documents tab, please contact us and we will be happy to assist you. Learn more